APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Tools for Cancer Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI Tools for Cancer Therapy Industry Growth and Trends Forecast to 2032

3 July 2026122 pages

Choose your research edition.

Industry ResearchAI Tools for Cancer Therapy Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Tools for Cancer Therapy Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal AI Tools for Cancer Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Tools for Cancer Therapy Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Tools for Cancer Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global AI Tools for Cancer Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Tools for Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI Tools for Cancer Therapy market include Siemens Healthineers, GE Healthcare, ConcertAI, Medtronic, Roche, Oracle, NVIDIA, Philips and PathAI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI Tools for Cancer Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI Tools for Cancer Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Tools for Cancer Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Tools for Cancer Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI Tools for Cancer Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI Tools for Cancer Therapy Market by Company

Siemens Healthineers

GE Healthcare

ConcertAI

Medtronic

Roche

Oracle

NVIDIA

Philips

PathAI

CureMetrix

Mindpeak

Paige AI

Predictive Oncology

Exscientia

Insilico Medicine

Iktos

Tempus

Azra AI

CureMatch

OncoLens

Triomics

Clinakos

Perthera

Cellworks Group

Biomy

AI Tools for Cancer Therapy Segment by Type

Solid Tumors

Hematological Malignancies

Others

AI Tools for Cancer Therapy Segment by Application

Hospitals

Pharmaceuticals

Research Institutes

Others

AI Tools for Cancer Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Tools for Cancer Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Tools for Cancer Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Tools for Cancer Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI Tools for Cancer Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI Tools for Cancer Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI Tools for Cancer Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI Tools for Cancer Therapy Market Share by Region (2021-2026) Table 4. Global AI Tools for Cancer Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI Tools for Cancer Therapy Market Share by Region (2027-2032) Table 6. Global AI Tools for Cancer Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI Tools for Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI Tools for Cancer Therapy Market Size Share by Type (2021-2026) Table 9. Global AI Tools for Cancer Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI Tools for Cancer Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI Tools for Cancer Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI Tools for Cancer Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI Tools for Cancer Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI Tools for Cancer Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI Tools for Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI Tools for Cancer Therapy Market Size Share by Application (2021-2026) Table 24. Global AI Tools for Cancer Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI Tools for Cancer Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI Tools for Cancer Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI Tools for Cancer Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI Tools for Cancer Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI Tools for Cancer Therapy Industry Trends Table 37. AI Tools for Cancer Therapy Industry Drivers Table 38. AI Tools for Cancer Therapy Industry Opportunities and Challenges Table 39. AI Tools for Cancer Therapy Industry Restraints Table 40. Global AI Tools for Cancer Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI Tools for Cancer Therapy Revenue Market Share by Company (2021-2026) Table 42. Global AI Tools for Cancer Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI Tools for Cancer Therapy Key Company Headquarters & Area Served Table 44. Global AI Tools for Cancer Therapy Company, Product Type & Application Table 45. Global AI Tools for Cancer Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI Tools for Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Siemens Healthineers Company Information Table 49. Siemens Healthineers Business Overview Table 50. Siemens Healthineers AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio Table 52. Siemens Healthineers Recent Development Table 53. GE Healthcare Company Information Table 54. GE Healthcare Business Overview Table 55. GE Healthcare AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. GE Healthcare AI Tools for Cancer Therapy Product Portfolio Table 57. GE Healthcare Recent Development Table 58. ConcertAI Company Information Table 59. ConcertAI Business Overview Table 60. ConcertAI AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. ConcertAI AI Tools for Cancer Therapy Product Portfolio Table 62. ConcertAI Recent Development Table 63. Medtronic Company Information Table 64. Medtronic Business Overview Table 65. Medtronic AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Medtronic AI Tools for Cancer Therapy Product Portfolio Table 67. Medtronic Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Roche AI Tools for Cancer Therapy Product Portfolio Table 72. Roche Recent Development Table 73. Oracle Company Information Table 74. Oracle Business Overview Table 75. Oracle AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Oracle AI Tools for Cancer Therapy Product Portfolio Table 77. Oracle Recent Development Table 78. NVIDIA Company Information Table 79. NVIDIA Business Overview Table 80. NVIDIA AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. NVIDIA AI Tools for Cancer Therapy Product Portfolio Table 82. NVIDIA Recent Development Table 83. Philips Company Information Table 84. Philips Business Overview Table 85. Philips AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Philips AI Tools for Cancer Therapy Product Portfolio Table 87. Philips Recent Development Table 88. PathAI Company Information Table 89. PathAI Business Overview Table 90. PathAI AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. PathAI AI Tools for Cancer Therapy Product Portfolio Table 92. PathAI Recent Development Table 93. CureMetrix Company Information Table 94. CureMetrix Business Overview Table 95. CureMetrix AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CureMetrix AI Tools for Cancer Therapy Product Portfolio Table 97. CureMetrix Recent Development Table 98. Mindpeak Company Information Table 99. Mindpeak Business Overview Table 100. Mindpeak AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Mindpeak AI Tools for Cancer Therapy Product Portfolio Table 102. Mindpeak Recent Development Table 103. Paige AI Company Information Table 104. Paige AI Business Overview Table 105. Paige AI AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Paige AI AI Tools for Cancer Therapy Product Portfolio Table 107. Paige AI Recent Development Table 108. Predictive Oncology Company Information Table 109. Predictive Oncology Business Overview Table 110. Predictive Oncology AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Predictive Oncology AI Tools for Cancer Therapy Product Portfolio Table 112. Predictive Oncology Recent Development Table 113. Exscientia Company Information Table 114. Exscientia Business Overview Table 115. Exscientia AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Exscientia AI Tools for Cancer Therapy Product Portfolio Table 117. Exscientia Recent Development Table 118. Insilico Medicine Company Information Table 119. Insilico Medicine Business Overview Table 120. Insilico Medicine AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Insilico Medicine AI Tools for Cancer Therapy Product Portfolio Table 122. Insilico Medicine Recent Development Table 123. Iktos Company Information Table 124. Iktos Business Overview Table 125. Iktos AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Iktos AI Tools for Cancer Therapy Product Portfolio Table 127. Iktos Recent Development Table 128. Tempus Company Information Table 129. Tempus Business Overview Table 130. Tempus AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Tempus AI Tools for Cancer Therapy Product Portfolio Table 132. Tempus Recent Development Table 133. Azra AI Company Information Table 134. Azra AI Business Overview Table 135. Azra AI AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Azra AI AI Tools for Cancer Therapy Product Portfolio Table 137. Azra AI Recent Development Table 138. CureMatch Company Information Table 139. CureMatch Business Overview Table 140. CureMatch AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. CureMatch AI Tools for Cancer Therapy Product Portfolio Table 142. CureMatch Recent Development Table 143. OncoLens Company Information Table 144. OncoLens Business Overview Table 145. OncoLens AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. OncoLens AI Tools for Cancer Therapy Product Portfolio Table 147. OncoLens Recent Development Table 148. Triomics Company Information Table 149. Triomics Business Overview Table 150. Triomics AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Triomics AI Tools for Cancer Therapy Product Portfolio Table 152. Triomics Recent Development Table 153. Clinakos Company Information Table 154. Clinakos Business Overview Table 155. Clinakos AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Clinakos AI Tools for Cancer Therapy Product Portfolio Table 157. Clinakos Recent Development Table 158. Perthera Company Information Table 159. Perthera Business Overview Table 160. Perthera AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Perthera AI Tools for Cancer Therapy Product Portfolio Table 162. Perthera Recent Development Table 163. Cellworks Group Company Information Table 164. Cellworks Group Business Overview Table 165. Cellworks Group AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Cellworks Group AI Tools for Cancer Therapy Product Portfolio Table 167. Cellworks Group Recent Development Table 168. Biomy Company Information Table 169. Biomy Business Overview Table 170. Biomy AI Tools for Cancer Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Biomy AI Tools for Cancer Therapy Product Portfolio Table 172. Biomy Recent Development Table 173. North America AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million) Table 175. North America AI Tools for Cancer Therapy Market Share by Country (2021-2026) Table 176. North America AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America AI Tools for Cancer Therapy Market Share Forecast by Country (2027-2032) Table 178. Europe AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe AI Tools for Cancer Therapy Market Share by Country (2021-2026) Table 181. Europe AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe AI Tools for Cancer Therapy Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific AI Tools for Cancer Therapy Market Share by Country (2021-2026) Table 186. Asia-Pacific AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific AI Tools for Cancer Therapy Market Share Forecast by Country (2027-2032) Table 188. Latin America AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America AI Tools for Cancer Therapy Market Share by Country (2021-2026) Table 191. Latin America AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America AI Tools for Cancer Therapy Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa AI Tools for Cancer Therapy Market Share by Country (2021-2026) Table 196. Middle East & Africa AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa AI Tools for Cancer Therapy Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI Tools for Cancer Therapy Product Image Figure 3. Global AI Tools for Cancer Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI Tools for Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global AI Tools for Cancer Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global AI Tools for Cancer Therapy Market Share by Region (2021-2032) Figure 7. North America AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Solid Tumors Image Figure 13. Global Solid Tumors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Hematological Malignancies Image Figure 15. Global Hematological Malignancies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global AI Tools for Cancer Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global AI Tools for Cancer Therapy Market Share by Type 2025 VS 2032 Figure 20. North America AI Tools for Cancer Therapy Market Size Share by Type (2021-2032) Figure 21. Europe AI Tools for Cancer Therapy Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific AI Tools for Cancer Therapy Market Size Share by Type (2021-2032) Figure 23. Latin America AI Tools for Cancer Therapy Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa AI Tools for Cancer Therapy Market Size Share by Type (2021-2032) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Pharmaceuticals Image Figure 28. Global Pharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Research Institutes Image Figure 30. Global Research Institutes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global AI Tools for Cancer Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global AI Tools for Cancer Therapy Market Share by Application 2025 VS 2032 Figure 35. North America AI Tools for Cancer Therapy Market Size Share by Application (2021-2032) Figure 36. Europe AI Tools for Cancer Therapy Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific AI Tools for Cancer Therapy Market Size Share by Application (2021-2032) Figure 38. Latin America AI Tools for Cancer Therapy Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa AI Tools for Cancer Therapy Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 AI Tools for Cancer Therapy Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America AI Tools for Cancer Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America AI Tools for Cancer Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America AI Tools for Cancer Therapy Market Share by Country (2021-2032) Figure 45. Europe AI Tools for Cancer Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe AI Tools for Cancer Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe AI Tools for Cancer Therapy Market Share by Country (2021-2032) Figure 48. Asia-Pacific AI Tools for Cancer Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific AI Tools for Cancer Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific AI Tools for Cancer Therapy Market Share by Country (2021-2032) Figure 51. Latin America AI Tools for Cancer Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America AI Tools for Cancer Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America AI Tools for Cancer Therapy Market Share by Country (2021-2032) Figure 54. Middle East & Africa AI Tools for Cancer Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa AI Tools for Cancer Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa AI Tools for Cancer Therapy Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Tumors
  • Hematological Malignancies
  • Others
Applications
  • Hospitals
  • Pharmaceuticals
  • Research Institutes
  • Others
Companies covered
  • Siemens Healthineers
  • GE Healthcare
  • ConcertAI
  • Medtronic
  • Roche
  • Oracle
  • NVIDIA
  • Philips
  • PathAI
  • CureMetrix
  • Mindpeak
  • Paige AI
  • Predictive Oncology
  • Exscientia
  • Insilico Medicine
  • Iktos
  • Tempus
  • Azra AI
  • CureMatch
  • OncoLens
  • Triomics
  • Clinakos
  • Perthera
  • Cellworks Group
  • Biomy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI Tools for Cancer Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI Tools for Cancer Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global AI Tools for Cancer Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global AI Tools for Cancer Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI Tools for Cancer Therapy Market Size (2021-2032)
  8. 1.5.1 North America AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI Tools for Cancer Therapy Market Size Growth Rate (2021-2032)
2 AI Tools for Cancer Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Solid Tumors
  3. 2.1.2 Hematological Malignancies
  4. 2.1.3 Others
  5. 2.2 Global AI Tools for Cancer Therapy Market Size by Type
  6. 2.2.1 Global AI Tools for Cancer Therapy Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global AI Tools for Cancer Therapy Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global AI Tools for Cancer Therapy Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global AI Tools for Cancer Therapy Market Size by Regions
  10. 2.3.1 North America AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Type (2021-2026)
3 AI Tools for Cancer Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Pharmaceuticals
  4. 3.1.3 Research Institutes
  5. 3.1.4 Others
  6. 3.2 Global AI Tools for Cancer Therapy Market Size by Application
  7. 3.2.1 Global AI Tools for Cancer Therapy Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global AI Tools for Cancer Therapy Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global AI Tools for Cancer Therapy Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global AI Tools for Cancer Therapy Market Size by Regions
  11. 3.3.1 North America AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa AI Tools for Cancer Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI Tools for Cancer Therapy Industry Trends
  2. 4.2 AI Tools for Cancer Therapy Industry Drivers
  3. 4.3 AI Tools for Cancer Therapy Industry Opportunities and Challenges
  4. 4.4 AI Tools for Cancer Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI Tools for Cancer Therapy Revenue (2021-2026)
  2. 5.2 Global AI Tools for Cancer Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI Tools for Cancer Therapy Key Company Headquarters & Area Served
  4. 5.4 Global AI Tools for Cancer Therapy Company, Product Type & Application
  5. 5.5 Global AI Tools for Cancer Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI Tools for Cancer Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI Tools for Cancer Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI Tools for Cancer Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Siemens Healthineers
  2. 6.1.1 Siemens Healthineers Company Information
  3. 6.1.2 Siemens Healthineers Business Overview
  4. 6.1.3 Siemens Healthineers AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio
  6. 6.1.5 Siemens Healthineers Recent Developments
  7. 6.2 GE Healthcare
  8. 6.2.1 GE Healthcare Company Information
  9. 6.2.2 GE Healthcare Business Overview
  10. 6.2.3 GE Healthcare AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 GE Healthcare AI Tools for Cancer Therapy Product Portfolio
  12. 6.2.5 GE Healthcare Recent Developments
  13. 6.3 ConcertAI
  14. 6.3.1 ConcertAI Company Information
  15. 6.3.2 ConcertAI Business Overview
  16. 6.3.3 ConcertAI AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 ConcertAI AI Tools for Cancer Therapy Product Portfolio
  18. 6.3.5 ConcertAI Recent Developments
  19. 6.4 Medtronic
  20. 6.4.1 Medtronic Company Information
  21. 6.4.2 Medtronic Business Overview
  22. 6.4.3 Medtronic AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Medtronic AI Tools for Cancer Therapy Product Portfolio
  24. 6.4.5 Medtronic Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Roche AI Tools for Cancer Therapy Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Oracle
  32. 6.6.1 Oracle Company Information
  33. 6.6.2 Oracle Business Overview
  34. 6.6.3 Oracle AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Oracle AI Tools for Cancer Therapy Product Portfolio
  36. 6.6.5 Oracle Recent Developments
  37. 6.7 NVIDIA
  38. 6.7.1 NVIDIA Company Information
  39. 6.7.2 NVIDIA Business Overview
  40. 6.7.3 NVIDIA AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 NVIDIA AI Tools for Cancer Therapy Product Portfolio
  42. 6.7.5 NVIDIA Recent Developments
  43. 6.8 Philips
  44. 6.8.1 Philips Company Information
  45. 6.8.2 Philips Business Overview
  46. 6.8.3 Philips AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Philips AI Tools for Cancer Therapy Product Portfolio
  48. 6.8.5 Philips Recent Developments
  49. 6.9 PathAI
  50. 6.9.1 PathAI Company Information
  51. 6.9.2 PathAI Business Overview
  52. 6.9.3 PathAI AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 PathAI AI Tools for Cancer Therapy Product Portfolio
  54. 6.9.5 PathAI Recent Developments
  55. 6.10 CureMetrix
  56. 6.10.1 CureMetrix Company Information
  57. 6.10.2 CureMetrix Business Overview
  58. 6.10.3 CureMetrix AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CureMetrix AI Tools for Cancer Therapy Product Portfolio
  60. 6.10.5 CureMetrix Recent Developments
  61. 6.11 Mindpeak
  62. 6.11.1 Mindpeak Company Information
  63. 6.11.2 Mindpeak Business Overview
  64. 6.11.3 Mindpeak AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Mindpeak AI Tools for Cancer Therapy Product Portfolio
  66. 6.11.5 Mindpeak Recent Developments
  67. 6.12 Paige AI
  68. 6.12.1 Paige AI Company Information
  69. 6.12.2 Paige AI Business Overview
  70. 6.12.3 Paige AI AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Paige AI AI Tools for Cancer Therapy Product Portfolio
  72. 6.12.5 Paige AI Recent Developments
  73. 6.13 Predictive Oncology
  74. 6.13.1 Predictive Oncology Company Information
  75. 6.13.2 Predictive Oncology Business Overview
  76. 6.13.3 Predictive Oncology AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Predictive Oncology AI Tools for Cancer Therapy Product Portfolio
  78. 6.13.5 Predictive Oncology Recent Developments
  79. 6.14 Exscientia
  80. 6.14.1 Exscientia Company Information
  81. 6.14.2 Exscientia Business Overview
  82. 6.14.3 Exscientia AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Exscientia AI Tools for Cancer Therapy Product Portfolio
  84. 6.14.5 Exscientia Recent Developments
  85. 6.15 Insilico Medicine
  86. 6.15.1 Insilico Medicine Company Information
  87. 6.15.2 Insilico Medicine Business Overview
  88. 6.15.3 Insilico Medicine AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Insilico Medicine AI Tools for Cancer Therapy Product Portfolio
  90. 6.15.5 Insilico Medicine Recent Developments
  91. 6.16 Iktos
  92. 6.16.1 Iktos Company Information
  93. 6.16.2 Iktos Business Overview
  94. 6.16.3 Iktos AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Iktos AI Tools for Cancer Therapy Product Portfolio
  96. 6.16.5 Iktos Recent Developments
  97. 6.17 Tempus
  98. 6.17.1 Tempus Company Information
  99. 6.17.2 Tempus Business Overview
  100. 6.17.3 Tempus AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Tempus AI Tools for Cancer Therapy Product Portfolio
  102. 6.17.5 Tempus Recent Developments
  103. 6.18 Azra AI
  104. 6.18.1 Azra AI Company Information
  105. 6.18.2 Azra AI Business Overview
  106. 6.18.3 Azra AI AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Azra AI AI Tools for Cancer Therapy Product Portfolio
  108. 6.18.5 Azra AI Recent Developments
  109. 6.19 CureMatch
  110. 6.19.1 CureMatch Company Information
  111. 6.19.2 CureMatch Business Overview
  112. 6.19.3 CureMatch AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 CureMatch AI Tools for Cancer Therapy Product Portfolio
  114. 6.19.5 CureMatch Recent Developments
  115. 6.20 OncoLens
  116. 6.20.1 OncoLens Company Information
  117. 6.20.2 OncoLens Business Overview
  118. 6.20.3 OncoLens AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 OncoLens AI Tools for Cancer Therapy Product Portfolio
  120. 6.20.5 OncoLens Recent Developments
  121. 6.21 Triomics
  122. 6.21.1 Triomics Company Information
  123. 6.21.2 Triomics Business Overview
  124. 6.21.3 Triomics AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Triomics AI Tools for Cancer Therapy Product Portfolio
  126. 6.21.5 Triomics Recent Developments
  127. 6.22 Clinakos
  128. 6.22.1 Clinakos Company Information
  129. 6.22.2 Clinakos Business Overview
  130. 6.22.3 Clinakos AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Clinakos AI Tools for Cancer Therapy Product Portfolio
  132. 6.22.5 Clinakos Recent Developments
  133. 6.23 Perthera
  134. 6.23.1 Perthera Company Information
  135. 6.23.2 Perthera Business Overview
  136. 6.23.3 Perthera AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Perthera AI Tools for Cancer Therapy Product Portfolio
  138. 6.23.5 Perthera Recent Developments
  139. 6.24 Cellworks Group
  140. 6.24.1 Cellworks Group Company Information
  141. 6.24.2 Cellworks Group Business Overview
  142. 6.24.3 Cellworks Group AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Cellworks Group AI Tools for Cancer Therapy Product Portfolio
  144. 6.24.5 Cellworks Group Recent Developments
  145. 6.25 Biomy
  146. 6.25.1 Biomy Company Information
  147. 6.25.2 Biomy Business Overview
  148. 6.25.3 Biomy AI Tools for Cancer Therapy Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Biomy AI Tools for Cancer Therapy Product Portfolio
  150. 6.25.5 Biomy Recent Developments
7 North America
  1. 7.1 North America AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI Tools for Cancer Therapy Market Size by Country (2021-2026)
  3. 7.3 North America AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI Tools for Cancer Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI Tools for Cancer Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI Tools for Cancer Therapy Market Size by Country (2021-2026)
  3. 10.3 South America AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Tools for Cancer Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI Tools for Cancer Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst